Search

Your search keyword '"Lanman R"' showing total 16 results
Start Over Author "Lanman R" Database Complementary Index
16 results on '"Lanman R"'

3. Pharmacokinetics of 5-aminosalicylic acid from controlled-release capsules in man.

Author

Yu, D., Morrill, B., Eichmeier, L., Giesing, D., Weir, S., Lanman, R., and Lanman, M.

Abstract

One gram single dose of Pentasa controlled-release capsules was administered to 24 healthy volunteers under fasting condition. Mean plasma 5-aminosalicylic acid (5-ASA) and acetyl 5-ASA concentrations peaked at 0.53 μg · ml and 1.33 μg · ml from 3 to 4 hours following dosing, respectively. The half-lives of both compounds could not be determined as absorption of 5-ASA was continuous throughout the gastrointestinal tract. An average of 29.4% (CV: 27%) of the dose was excreted in the urine primarily as acetyl 5-ASA. Up to 91.1% of the dose was released from the capsules. Forty percent of the dose (CV: 40%) was eliminated in the feces, with 8.9% of the dose remained as formulation bounded 5-ASA, indicating that controlled-release capsules continue to release drug throughout the GI tract. 5-ASA contributed 46.7% of the salicylates eliminated in the feces and acetyl 5-ASA accounted for the balance. Controlled-release capsules produced three times more total salicylates and 10 times more total and free 5-ASA in the feces than did 5-ASA suspension. Thus, while lower systemic levels of salicylates were absorbed, greater therapeutic quantities of 5-ASA were available in the bowel. [ABSTRACT FROM AUTHOR]

Published
1995
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results